Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program

BackgroundThe JAVELIN Bladder 100 phase 3 trial demonstrated the efficacy and safety of avelumab administered as first-line (1L) maintenance treatment in patients with advanced urothelial carcinoma (UC) without disease progression after 1L platinum-based chemotherapy. This study provides the first r...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Se Hoon Park, Sang Joon Shin, Sun Young Rha, Seung-Hoon Beom, Ho Kyung Seo, Bhumsuk Keam, Miso Kim, Yoon-Hee Hong, Shinkyo Yoon, Jae-Lyun Lee
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2024-06-01
Serija:	Frontiers in Oncology
Teme:	urothelial carcinoma avelumab maintenance treatment platinum-based chemotherapy real-world
Online dostop:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1403120/full
Oznake:	Označite Brez oznak, prvi označite!